Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07189013

Assessing Patient Preference for Infusion Systems

This crossover study evaluates patient experiences and preferences between mechanical and electrical infusion pumps for subcutaneous immunoglobulin (SCIg) therapy. The Freedom Integrated Infusion System (FREEDOM60 and FreedomEdge) are mechanical, portable pumps that require no batteries or electricity and use Precision Flow Rate Tubing™ to control infusion speed. These devices are approved for use in the EU (CE650520).

Approximately 78 adult patients with primary or secondary immunodeficiency will participate. Participants will complete questionnaires assessing ease of training, ease of use, infusion comfort, and overall satisfaction. Patients experienced with electronic pumps will complete two questionnaires: one reflecting their current pump experience and one after trying the mechanical pump.

The primary goal is to determine whether mechanical pumps provide greater patient satisfaction than electrical pumps. Results will inform patient and healthcare professional decision-making regarding pump selection.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Primary Immunodeficiencies (PID) Immune System Diseases Immunologic Deficiency Syndromes Secondary Immunodeficiencies (SID)

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

About this study

Study Objective:

To assess patient preference, ease of training, ease of use, and satisfaction with mechanical versus electrical infusion pump systems.

Subject Population:

Adults with primary or secondary immunodeficiency receiving subcutaneous immunoglobulin therapy, including patients experienced with electronic infusion pumps.

Hypothesis:

Mechanical infusion pumps will provide greater patient satisfaction compared with electrical infusion pumps during SCIg treatment.

Study Assessments / Evaluations:

Experienced electronic pump users will complete two questionnaires: one reflecting their current pump experience and one after trying a mechanical pump. Comparisons will evaluate preference, satisfaction, ease of use, training, infusion comfort, handling, instructions, troubleshooting, and safety.

Number of Subjects:

Approximately 78 patients, completing 130 questionnaires in total.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • The subject has primary or secondary immunodeficiency or chronic inflammatory demyelinating polyneuropathy and is undergoing IgRT.
  • The subject or caregiver is willing and able to provide informed consent.
  • The subject has experience using electronic SCIG infusion system (3 months and above).

Exclusion criteria

  • The subject is participating in another clinical study prior to this study completion.
  • The subject has been on IgRT for less than 3 months.
  • The subject is less than 18 years old and/or has a legal representative

Treatment and study plan

Mechanical infusion pump

Device

Patients with earlier experience on electronic infusion pumps will crossover to the mechanical infusion pump for three month's period

Other names: Freedom60 Infusion Pump

Primary outcomes

  1. Change in Patient Satisfaction Scores Between Electronic and Mechanical Infusion Pumps Measured on a 5-Point Likert Scale Over 3 Months

    Time frame: Three months

    Participants will first provide a retrospective evaluation of their prior experience with an electronic infusion pump using a 5-point Likert scale (where 1 = worst outcome and 5 = best outcome). They will then crossover to a mechanical infusion pump for 3 months, after which satisfaction will again be assessed on the same scale. The primary outcome is the difference in satisfaction scores between electronic and mechanical pump use.

Secondary outcomes

  1. Change in Ease of Use Scores Between Electronic and Mechanical Infusion Pumps Measured on a 5-Point Likert Scale Over 3 Months

    Time frame: Three months

    Participants will first provide a retrospective evaluation of the ease of use of an electronic infusion pump using a 5-point Likert scale (1 = very difficult to use; 5 = very easy to use). They will then crossover to a mechanical infusion pump for 3 months, after which ease of use will again be assessed on the same scale. The secondary outcome is the difference in ease-of-use scores between electronic and mechanical pump use.

  2. Change in Handling Scores Between Electronic and Mechanical Infusion Pumps Measured on a 5-Point Likert Scale Over 3 Months

    Time frame: Three months

    Participants will first provide a retrospective evaluation of the handling of an electronic infusion pump using a 5-point Likert scale (1 = very difficult to handle; 5 = very easy to handle). They will then crossover to a mechanical infusion pump for 3 months, after which handling will again be assessed on the same scale. The secondary outcome is the difference in handling scores between electronic and mechanical pump use.

  3. Change in Scores for Clarity of Instructions of Use Between Electronic and Mechanical Infusion Pumps Measured on a 5-Point Likert Scale Over 3 Months

    Time frame: Three months

    Participants will first provide a retrospective evaluation of the clarity of instructions of use for an electronic infusion pump using a 5-point Likert scale (1 = very unclear instructions; 5 = very clear instructions). They will then crossover to a mechanical infusion pump for 3 months, after which clarity of instructions of use will again be assessed on the same scale. The secondary outcome is the difference in clarity-of-instructions scores between electronic and mechanical pump use.

  4. Change in Scores for Ability for Troubleshooting Between Electronic and Mechanical Infusion Pumps Measured on a 5-Point Likert Scale Over 3 Months

    Time frame: Three months

    Participants will first provide a retrospective evaluation of the ability for troubleshooting any issues that may arise during the infusion for an electronic infusion pump using a 5-point Likert scale (1 = not at all confident; 5 = very confident). They will then crossover to a mechanical infusion pump for 3 months, after which clarity of instructions of use will again be assessed on the same scale. The secondary outcome is the difference in ability for troubleshooting scores between electronic and mechanical pump use.

  5. Change in Scores for Pain and Discomfort Between Electronic and Mechanical Infusion Pumps Measured on a 5-Point Likert Scale Over 3 Months

    Time frame: Three months

    Participants will first provide a retrospective evaluation of the clarity of instructions of use for an electronic infusion pump using a 5-point Likert scale (1 = extreme pain and discomfort; 5 = no pain and discomfort). They will then crossover to a mechanical infusion pump for 3 months, after which clarity of instructions of use will again be assessed on the same scale. The secondary outcome is the difference in clarity-of-instructions scores between electronic and mechanical pump use.

Study contacts

Contact information is provided by the study sponsor or research team.

Anna Majapuro-Hirvonen

CONTACT

[email protected]

+358405697866

Sponsors and collaborators

Lead sponsor

KORU Medical Systems, Inc.

Industry

Registry information

Official study title

Assessing Patient Preference for Infusion Systems (Electronic vs. Mechanical)

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Sep 23, 2025
Registry last updated
Sep 23, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.